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Preferential Enhancement of Dopamine Transmission within
the Nucleus Accumbens Shell by Cocaine Is Attributable to a
Direct Increase in Phasic Dopamine Release Events
Brandon J. Aragona,1,2 Nathan A. Cleaveland,2 Garret D. Stuber,2 Jeremy J. Day,2 Regina M. Carelli,2,3 and
R. Mark Wightman1,3
Departments of 1Chemistry and 2Psychology and 3Neuroscience Center and Curriculum in Neurobiology, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina 27599-3290
Preferential enhancement of dopamine transmission within the nucleus accumbens (NAc) shell is a fundamental aspect of the neural
regulation of cocaine reward. Despite its importance, the nature of this effect is poorly understood. Here, we used fast-scan cyclic
voltammetry to examine specific transmission processes underlying cocaine-evoked increases in dopamine transmission within the NAc
core and shell. Initially, we examined altered terminal dopamine concentrations after global autoreceptor blockade. This was the first
examination of autoreceptor regulation of naturally occurring phasic dopamine transmission and provided a novel characterization of
specific components of dopamine neurotransmission. Comparison of increased dopamine signaling evoked by autoreceptor blockade
and cocaine administration allowed robust resolution between increased frequency, concentration, and duration of phasic dopamine
release events after cocaine delivery. Cocaine increased dopamine transmission by slowed uptake and increased concentration of dopa-
mine released in the core and shell. However, an additional increase in the number phasic release events occurred only within the NAc
shell, and this increase was eliminated by inactivation of midbrain dopaminergic neurons. This represents the first evidence that cocaine
directly increases the frequency of dopamine release events and reveals that this is responsible for preferentially increased dopamine
transmission within the NAc shell after cocaine administration. Additionally, cocaine administration resulted in a synergistic increase in
dopamine concentration, and subregion differences were abolished when cocaine was administered in the absence of autoregulation.
Together, these results demonstrate that cocaine administration results in a temporally and regionally specific increase in phasic dopa-
mine release that is significantly regulated by dopamine autoreceptors.
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Introduction
The reinforcing properties of cocaine are significantly mediated
by enhanced dopamine transmission (Kelley, 2004; Wise, 2004;
Everitt and Robbins, 2005), and cocaine exerts its greatest in-
crease in extracellular dopamine concentration ([DA]) within
the shell subregion of the nucleus accumbens (NAc) (Di Chiara
and Bassareo, 2007). Cocaine increases [DA] by slowing uptake
via blockade of dopamine transporters (DATs) (Giros et al.,
1996) and by increasing the amount of dopamine exocytosed
through mobilization of vesicles normally unavailable for release
(Venton et al., 2006). However, neither mechanism can account
for preferential enhancement of dopamine transmission within
the NAc shell, because both are mediated through terminal DATs
and DAT expression is significantly lower in the NAc shell com-
pared with the core (Nirenberg et al., 1997).
It has been suggested that this paradox may be explained by an
increased number of dopamine release events within the shell
after cocaine administration (Di Chiara and Bassareo, 2007).
However, this hypothesis cannot be confirmed using microdialy-
sis because it measures general increases in [DA] without resolv-
ing specific transmission processes, such as release and uptake
(Wightman et al., 1988). It is often suggested that dopamine re-
lease can be inferred from electrophysiological assessment of do-
paminergic neuron activity (Schultz, 2002). However, dopamine
signaling is significantly modulated by terminal transmission
(Cragg, 2006; Britt and McGehee, 2008), and extracellular elec-
trophysiological identification of a dopaminergic phenotype can
be unreliable (Margolis et al., 2006). Therefore, unambiguous
assessment of terminal dopamine release events requires real-
time measurements of [DA].
This is robustly achieved, in freely moving subjects, with fast-
scan cyclic voltammetry (FSCV) (Wightman et al., 2007). FSCV
uses subsecond measurements that resolve specific components
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of phasic dopamine transmission: the occurrence of a release
event, the concentration of dopamine released (i.e., exocytosed),
and the duration of increased [DA] (Wightman et al., 1988).
Although these features have been characterized using electrically
stimulated dopamine release (Wightman and Zimmerman,
1990), the present study required distinction between transmis-
sion components after cocaine administration. Thus, it was nec-
essary to provide pharmacological characterization of drug-
evoked alterations in naturally occurring phasic dopamine
release events, i.e., dopamine “transients” (Wightman and Rob-
inson, 2002).
Here, transient characterization was facilitated by manipulat-
ing dopamine autoreceptors because their regulation of dopa-
mine transmission is extremely well understood (White, 1996).
Comparisons of real-time measurements after cocaine adminis-
tration and systemic blockade of dopamine autoreceptors pro-
vided reliable resolution between increases in the frequency of
dopamine release events and the concentration of dopamine re-
leased. Using these distinctions, we show that preferential en-
hancement of dopamine transmission within the NAc shell
evoked by cocaine is attributable to a greater number of phasic
release events originating from midbrain dopaminergic neuron
activity. This subregion difference was abolished by autoreceptor
blockade before cocaine administration. Finally, cocaine admin-
istration in the absence of autoregulation resulted in a synergistic
increase in [DA]. Together, this study provides novel character-
ization of the distinct processes that encompass extracellular do-
pamine transmission, shows the first evidence that cocaine di-
rectly increases dopamine release events in a temporally and
regionally specific manner, and demonstrates the significance of
autoregulation in cocaine-evoked dopamine transmission.
Materials and Methods
Animals and surgery. Male Sprague Dawley rats purchased with im-
planted jugular vein catheters (n  30; 325 g; Charles River Laborato-
ries). Rats were anesthetized with ketamine hydrochloride (100 mg/kg,
i.p.) and xylazine hydrochloride (20 mg/kg, i.p.). Ag/AgCl reference elec-
trodes (placed in contralateral cortex) and bipolar stimulating electrodes
(Plastics One) [placed in the ventral tegmental area (VTA); 5.2 mm
posterior, 1.0 mm lateral, 7.5 mm ventral relative to bregma (Paxinos and
Watson, 1998)] were secured as described in detail previously (P. E.
Phillips et al., 2003; Wightman et al., 2007). Guide cannulas (Bioanalyti-
cal Systems) were aimed at the NAc core (1.3 mm anterior, 1.3 mm
lateral, 2.5 mm ventral) or shell (1.7 mm anterior, 0.8 mm lateral, 2.5
mm ventral relative to bregma). These placements are within rostral
portions of the NAc shell, which has greater [DA] (Heidbreder and Fel-
don, 1998) and negligible noradrenergic input (Delfs et al., 1998; Baldo et
al., 2003) compared with caudal portions. After the experiment, an elec-
trolytic lesion was made at the microdrive setting used during the exper-
iment and verified histologically. All experiments were approved by the
Institutional Animal Care and Use Committee at the University of North
Carolina at Chapel Hill.
Fast-scan cyclic voltammetry. After 5–7 d recovery from surgery, glass-
encased carbon-fiber electrodes were lowered using a locally constructed
microdrive (University of North Carolina at Chapel Hill, Department of
Chemistry Instrument Shop) and positioned where both electrically
evoked (biphasic pulses, 2 ms/phase, 24 pulses, 60 Hz, 120 A) and
transients were detected (Wightman et al., 2007). Waveform generation
and processing, current transduction, and data collection and filtering
have been described in detail previously (Wightman et al., 2007). To
ensure that the signal of interest was attributable to dopamine and not
other analytes, current was converted to [DA] using principal compo-
nent regression as described previously (Heien et al., 2005). Consistent
with previous studies (Heien et al., 2005), a dopamine transient was
defined as a fivefold or greater surge in [DA] relative to the root-mean-
square noise value taken from the same electrode. Events that met this
criterion were rarely below 30 nM, and transients below 30 nM were not
reliably detected across electrodes and were therefore excluded from the
analysis. The conservative criterion used ensured that all measurements
occurred beyond the electrochemical baseline associated with FSCV that
primarily comprises undifferentiated chemical and electrical noise
(Wightman et al., 2007) and digitally subtracted from the signal of inter-
est (Heien et al., 2005). Transient amplitude and half-width were deter-
mined with Mini Analysis (Synaptosoft) with the first minima 300 – 600
ms before the peak serving as the baseline (Cheer et al., 2007b). Tran-
sients above 30 nM were accurately identified by the “differential
method” for transient detection (Heien et al., 2005), and this analysis was
therefore used to determine transient frequency. For the differential
method, cyclic voltammograms were compared with that of electrically
evoked dopamine release from the same subject (Stuber et al., 2005).
Cyclic voltammograms with a correlation coefficient 0.86 were as-
signed to dopamine, and a 40% decay defined transient termination
(Heien et al., 2005; Stuber et al., 2005). Mean increases in [DA] relative to
the zero point established by background subtraction applied to the raw
data after drug treatment are obtained from averaging [DA] traces result-
ing from principal component regression. Change in mean [DA] was
restricted to a 90 s sampling period because electrode drift prevents reli-
able analysis beyond this point for most electrodes (Heien et al., 2005).
After the experiment, electrodes were calibrated as described previously
(Wightman et al., 2007). All chemicals were purchased from
Sigma-Aldrich.
VTA microinfusions. Microinfusions were made into a cannula at-
tached to the stimulating electrode (Plastics One) directed at the VTA
using a syringe pump with a flow rate of 0.5 l/min. A within-subjects
design (n  5) was used in which vehicle (0.5 l of sterile saline) or the
GABA agonists (50 ng baclofen/5 ng muscimol) were delivered in a coun-
terbalanced manner with the second infusion occurring after the baseline
frequency of dopamine transients was reestablished, 45 min later. Each
microinfusion was followed 1 min later by a slightly lower dose cocaine
(coc) infusion (2 mg/kg, i.v.) compared with that used in the primary
experimental design (3 mg/kg, i.v.). This lower dose resulted in a statis-
tically equivalent increase in cocaine-evoked transient frequency com-
pared with 3 mg/kg infusion. The lower dose was chosen to minimize
recovery time between infusions in an attempt to reduce the length of the
experiment. A minimum duration is desired for a within-subjects design
because it increases the likelihood of equivalent electrode stability across
time. After the experiment, 0.5 l of a 2% Chicago Sky Blue solution was
infused into the VTA immediately before the animal was perfused. Sub-
jects showed dye covering 70% of the VTA [including cellular sub-
populations that project to the shell (Ikemoto, 2007)] with minimal
staining of structures outside of the VTA.
Statistics. Changes in [DA], transient frequency, and transient ampli-
tude after raclopride (rac) and cocaine administration were assessed us-
ing linear mixed models, which were chosen based on their ability to
properly handle data in which observations are not independent (such as
repeated measures data), correctly model correlated error terms, and
incorporate random-subject effects. To determine mean changes of
[DA], measurements were averaged into 2.5 s time bins and treated as the
dependent variable, with time serving both as a repeated measure and
fixed-effect variable. Estimation of time bins at which concentration dif-
fered from predrug baselines was achieved by construction of simple
slopes and comparison of corresponding critical T values to the reference
period (10 s before drug infusion; “predrug”). Core and shell differences
were assessed by including region as a fixed-effect variable, enabling
investigation of location effects and time  location interactions. Tran-
sient frequency and amplitude followed Poisson and  distributions,
respectively. For transient frequency, time (in 1 min bins) was treated as
a repeated and fixed effect, and region was treated as a fixed effect. Time
points during a given experimental condition in which transient fre-
quency differed from the preceding condition were determined by com-
paring all time points of the session of interest to a fixed baseline value of
the preceding session that was based on the mean transient frequency
over the last 2 min of the recording session (which never differed between
subregions). Although there were no statistical differences between core
and shell, frequency within the shell was consistently higher after saline
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administration in coc–rac subjects. Therefore, transient frequency after
saline in this group of subjects was included as a covariate for analysis
after drug administration. For transient amplitude, both region (core vs
shell) and amplitude distribution (in 10 nM bins) were treated as fixed
effects, enabling analysis of subregion and drug-induced differences in
transient concentration. Changes in mean cocaine-induced transient fre-
quency after VTA inactivation were assessed during the first 3 min after
cocaine infusion, using a one-way repeated measures ANOVA with Stu-
dent–Newman–Keuls post hoc tests. Mean transient half-width over the
entire duration of each recording session was compared using a one-way
ANOVA with Student–Newman–Keuls post hoc test. Statistical signifi-
cance was designated at   0.01 for mixed-
model analyses and at   0.05 for ANOVA and
post hoc comparisons. All statistical analyses
were performed in SPSS version 14 for Win-





man, 2006) were secured in discrete loca-
tions (6  100 m) that supported electri-
cally stimulated and naturally occurring
dopamine release (Wightman et al., 2007).
Real-time fluctuations in [DA] were mea-
sured during a series of 15 min recording
sessions (Fig. 1A,B). At the completion of
each session, electrode stability was tested
by stimulation of dopaminergic neurons
(60 Hz, 24 pulses, 120 A) (Fig. 1A,B).
Experiments began with a baseline re-
cording session (Fig. 1A,B) followed by a
control session that tested the effects of in-
travenous saline infusion (0.2 ml; 6 s) (Fig.
1A,B). At the beginning of the next re-
cording session, rac/coc subjects received
intravenous infusion of the D2-type dopa-
mine receptor antagonist raclopride (1
mg/kg), followed 20 min later by intrave-
nous infusion of cocaine (3 mg/kg) (Fig.
1A). A separate set of subjects, referred to
as coc/rac, received the reverse order of
drug administration: cocaine followed 20
min later by raclopride (Fig. 1B). Data
from the NAc core and shell (Fig. 1C,D)
were analyzed separately.
Phasic dopamine transmission
Neurochemical changes at all potentials of
the measurement scan (oxidative scan,
0.4 to 1.3 V; reductive scan, 1.3 to 0.4
V) were visualized by plotting current
changes in false color (Michael et al., 1999)
(Fig. 2A). The dopamine oxidation peak
occurs at 0.65 V and the reduction peak
at 0.2 V (Fig. 2A). The cyclic voltamma-
gram is converted to [DA] using principal
component regression (Heien et al., 2005)
(Fig. 2B). Consistent with previous studies
(Gonon, 1988), the color plot (Fig. 2A)
and corresponding concentration trace
(Fig. 2B) show that stimulation of dopa-
minergic neurons that mimics synchro-
nous burst firing (20 Hz, 4 pulses, 120 A)
(Grace and Bunney, 1984b) results in phasic dopamine release. In
contrast to interpretations suggesting that only a small amount of
phasic dopamine release escapes the synapse (Floresco et al.,
2003), the extracellular [DA] resulting from this release event was
150 nM (Fig. 2B).
FSCV also detects naturally occurring phasic dopamine re-
lease events that are termed dopamine transients (Wightman and
Robinson, 2002). In the seconds following electrical stimulation,
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Figure 1. Experimental design and histology. A, B, Recording sessions (indicated by arrows) were followed by electrical
stimulation of dopaminergic cell bodies (indicated by boxes after the arrows). Subsequent recording sessions began 5 min after
stimulation offset. Specific manipulations are color coded throughout the study, with baseline (no manipulation) recordings
coded as white and saline control sessions as black. A, rac/coc subjects received raclopride infusions (1 mg/kg; 6 s) (green) followed
by cocaine (3 mg/kg; 6 s) (gray). B, coc/rac subjects received cocaine (orange) followed by raclopride (blue). C, For rac/coc subjects,
dopamine measurements were conducted in either the NAc core (n  7) or shell (n  6). D, Measurements for coc/rac subjects
were also conducted in either the core (n  7) or shell (n  5).



















Figure 2. Analysis of dopamine transients. A, The holding potential applied to the carbon-fiber electrode (0.4 V) was
ramped to 1.3 V and back 10 times per second. Oxidation and reduction reactions at the carbon surface result in changes in current
that are plotted in false color. Dopamine release evoked by electrical stimulation (white dashed line) and naturally occurring
dopamine transients (inverted white triangles) appear as brief green events at the potential of peak dopamine oxidation (0.65
V). B, Current was converted into [DA] and amplitudes for stimulated release (boxes on the trace indicate stimulation onset and
offset), and transients are displayed above each event (indicated by orange circles). The point at which half-width was calculated
is shown by the orange dashed lines, and the half-width values are given below.
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cause (Fig. 2A,B). Concentrations of do-
pamine transients are consistent with the
contents of dopamine vesicles (0.5 M)
(Sulzer and Pothos, 2000) being released
and diluted in the extracellular volume
(Garris et al., 1994; Cragg and Rice, 2004).
Typical transient magnitudes result in a
twofold to fivefold phasic increase over
basal [DA] (20 nM) (Shou et al., 2006)
and are within the range of binding affini-
ties for dopamine receptors (Richfield et
al., 1989). The physiological relevance of
concentrations measured by FSCV is also
attributed to the minimal tissue damage
caused by the microsensors used (Peters et
al., 2004).
Critically, measuring dopamine tran-
sients allows the investigation of specific
components of phasic dopamine signal-
ing. Transient detection reveals the occur-
rence of a dopamine release event, tran-
sient amplitude reflects the amount of
dopamine exocytosed, and transient half-
width represents the duration of a surge in
[DA] (Robinson and Wightman, 2007)
(Fig. 2B). The goal of the present study was
to use these measurements (transient fre-
quency, amplitude, and half-width) to assess the contribution of
phasic dopamine transmission to increased [DA] induced by au-
toreceptor blockade and cocaine administration. However, it was
first necessary to quantify drug-evoked increases in [DA] within
the NAc core and shell.
Real-time fluctuations in dopamine concentration
Quantification of drug-evoked increases in [DA] (which includes
tonic and phasic contributions) was accomplished by continuous
measurement of concentration fluctuations over a 90 s sampling
window encompassing intravenous drug infusion (Heien et al.,
2005). Measurements began 10 s before drug infusion and con-
tinued as initial drug effects were observed (10 –20 s after infu-
sion) and 1 min thereafter. Representative examples after admin-
istration of raclopride demonstrate robust increases in [DA] in
the NAc core (Fig. 3A) and shell (Fig. 3B). Although these in-
creases partly comprised a gradual rise in [DA], increased dopa-
mine transmission was primarily driven by a robust increase in
the frequency of phasic release events. Insets allow closer inspec-
tion of individual transients and emphasize the high amplitude
and long duration of these phasic release events (Fig. 3A,B).
In the NAc core, cocaine induced a gradual increase in [DA]
indicative of slowed uptake of ongoing release events (Fig. 3C)
(Venton et al., 2003; Wightman et al., 2007). The inset shows that
dopamine transients remained superimposed on the gradual rise
(Fig. 3C). However, their initial magnitude was low compared
with that after autoreceptor blockade. Conversely, within the
NAc shell, cocaine caused a more rapid and robust increase in
[DA] (Fig. 3D). Dopamine transients superimposed on the grad-
ual rise (Fig. 3D, inset) achieved concentrations and durations
similar to those seen after autoreceptor blockade, and slowed
uptake of these events (mediated by cocaine binding to terminal
DATs) facilitated the accumulation of dopamine in the extracel-
lular space.
Quantification of concentration changes
For quantification of changes in [DA], traces were averaged
across subjects. Saline infusion did not alter [DA] in the NAc core
(see Figs. 4A, 5A) or shell (see Figs. 4B, 5B). However, raclopride
administration evoked robust increases in [DA] in both subre-
gions (Fig. 4A,B). For statistical analysis, concentration data
were binned every 2.5 s. Raclopride significantly increased [DA]
compared with predrug levels beginning 17.5 and 25 s after infu-
sion onset in the shell and core, respectively (Fig. 4C). [DA] was
significantly greater in the shell compared with the core soon
after infusion onset (17.5–30 s) but not thereafter (Fig. 4C). Sub-
region differences were not attributable to electrode placement or
sensitivity because electrically stimulated dopamine release after
raclopride administration did not differ between subregions
(supplemental Figs. S1A,B, S2A,B, available at www.
jneurosci.org as supplemental material).
Consistent with previous studies (Stuber et al., 2005), cocaine-
evoked increases in [DA] within the NAc core began to rise 30
s after drug infusion (Fig. 5A) but were not significantly increased
over predrug levels until 50 s after infusion onset (Fig. 5C).
Within the shell, cocaine-evoked increases in [DA] were evident
10 s after infusion onset (Fig. 5B) and were significantly in-
creased over predrug levels beginning at 17.5 s (Fig. 5C). Further-
more, [DA] was significantly greater within the shell compared
with the core from 17.5 s after infusion onset and remained
higher throughout the sampling period (Fig. 5C). Subregion dif-
ferences were not attributable to differences in terminal release
potential because electrically stimulated dopamine release did
not differ between the core and shell before or after cocaine ad-
ministration (supplemental Fig. S1C,D, S2C,D, available at
www.jneurosci.org as supplemental material).
Consistent with microdialysis studies (Rouge-Pont et al.,
2002), cocaine administration in the absence of autoregulation
(via raclopride pretreatment) induced a synergistic increase in
[DA] (Fig. 4A,B). [DA] was significantly greater than predrug
levels at 7.5 and 12.5 s after infusion onset in the core and shell,
A  raclopride - core B  raclopride - shell


































Figure 3. Representative examples of increases in dopamine concentration during drug delivery. A–D, Individual examples of
90 s [DA] traces across intravenous drug infusion (indicated by yellow boxes; 6 s; 0.2 ml). Insets provide increased resolution of
naturally occurring transient events. A, B, Raclopride-evoked changes in [DA] within the NAc core (A) and NAc shell (B). C,
Cocaine-evoked changes in [DA] within the NAc core (C) and NAc shell (D).
8824 • J. Neurosci., August 27, 2008 • 28(35):8821– 8831 Aragona et al. • Cocaine-Evoked Dopamine Release
respectively (Fig. 4D). Cocaine-evoked increases in the presence
of raclopride did not differ across subregions (Fig. 4D), suggest-
ing that autoreceptors mediate subregion differences evoked by
cocaine alone (Fig. 5C).
Similar increases were observed when
raclopride was administered in the pres-
ence of cocaine (Fig. 5A,B). Raclopride-
evoked increases in [DA] occurred sooner
in the shell (10 s) compared with the core
(20 s). Although there was a trend for
greater raclopride-evoked [DA] (in the
presence of cocaine) within the shell early
in the sampling period (Fig. 5D), this did
not reach statistical significance. Impor-
tantly, such robust increases within the
NAc core demonstrate that the modest in-
crease in [DA] within the core after co-
caine administration alone (Fig. 5A,C)
was not attributable to a lower release po-
tential within this subregion.
Finally, the magnitude of synergistic
increases differed depending on drug or-
der. In both the core and shell, peak [DA]
was significantly higher when cocaine was
given in the presence of raclopride (5.09 
0.61 M) (Fig. 4D) compared with raclo-
pride administration in the presence of co-
caine (1.80  0.24 M; p  0.001) (Fig.
5D). This is most likely attributable to the
diminished effects of cocaine in 20 min,
whereas raclopride effects are stable for 1 h.
Transient frequency
Although real-time assessment of changes
in [DA] provided unprecedented infor-
mation regarding the timing and magni-
tude of drug-evoked increases in dopa-
mine signaling, this analysis alone does not
directly address the underlying nature of
enhanced dopamine transmission. To de-
termine the contribution of specific trans-
mission processes to increases in [DA],
dopamine transients were analyzed. Data
were background subtracted every 30 s
(Cheer et al., 2007b; Wightman et al.,
2007) to permit transient analysis across
recording sessions, and transient fre-
quency was quantified to determine drug-
evoked alterations in phasic dopamine re-
lease events.
Control infusions of saline did not sig-
nificantly increase transient frequency
compared with the baseline session (base-
line data not shown) (Fig. 6A,B). How-
ever, raclopride administration increased
transient frequency to a similar degree in
both subregions for the entire recording
session (Fig. 6A). This demonstrates that
global autoreceptor blockade results in a
stable increase in phasic dopamine release
events. Given that transient frequency did
not differ between the core and shell, sub-
region differences in raclopride-evoked
increases in [DA] concentration (Fig. 4C) are not attributable to
differences in the number of release events. Importantly, with
phasic release events increased by raclopride administration, co-
caine administration equally increased transient frequency (rela-
0 90
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Figure 4. Average drug-evoked increases in dopamine concentration and core–shell comparisons: rac/coc subjects. A, B, Mean
concentration traces (solid lines) and mean plus SE (dashed lines) for saline (black), raclopride (rac; green), and cocaine in the
presence of raclopride (rac-coc; gray) are superimposed on one another. Yellow boxes indicate the time of drug infusion. A, B,
Drug-evoked [DA] changes within the NAc core (A) and NAc shell (B). C, D, [DA] was binned every 2.5 s for comparisons between
the core and shell after raclopride (rac) administration C and cocaine administration in the presence of raclopride (rac-coc; D). Data
from the NAc shell are displayed by open circles, and data from the core are shown as filled circles. Error bars indicate SEM.  signs
indicate statistical significance ( p  0.01) between groups identified by their appropriate color-coded symbol. An asterisk inside
the symbol indicates when drug-evoked [DA] is significantly greater compared with [DA] before drug infusion.
0 90 0 90Time (2.5 s bins)
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Figure 5. Average drug-evoked increases in dopamine concentration and core–shell comparisons: coc/rac subjects. Mean
concentration traces (solid lines) and mean plus SE (dashed lines) for saline (black), cocaine (coc; orange), and raclopride in the
presence of cocaine (coc-rac; blue) are superimposed on one another. Yellow boxes indicate the time of drug infusion. A, B,
Drug-evoked [DA] changes within the NAc core (A) and NAc shell (B). C, D, [DA] was binned every 2.5 s for comparisons between
the core and shell after cocaine (coc) administration (C) and raclopride administration in the presence of cocaine (coc-rac; D). Data
from the NAc shell are displayed by open circles, and data from the core are shown as filled circles. Error bars indicate SEM.  signs
indicate statistical significance ( p  0.01) between groups identified by their appropriate color-coded symbol. An asterisk inside
the symbol indicates when drug-evoked [DA] is significantly greater compared with [DA] before drug infusion.
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tive to the end of the raclopride session)
within the NAc core and shell (Fig. 6A).
Within the NAc core, cocaine adminis-
tration induced a significant (but modest
compared with raclopride) increase in
transient frequency compared with the sa-
line condition for the entire recording ses-
sion (Fig. 6B). Raclopride administration
(in the presence of cocaine) resulted in a
robust increase in transient frequency
compared with cocaine administration
alone (Fig. 6B). Because transient detec-
tion is maximal after DAT blockade (Rob-
inson and Wightman, 2004), this
raclopride-evoked increase represents a
true increase in the number of release
events and is therefore a reliable index of a
neurochemical consequence of increased
dopaminergic neuron firing induced by
autoreceptor blockade (White, 1996). Fur-
thermore, it confirms that the NAc core
has the capacity for robust increases in
phasic release events but simply did not
respond in this manner after cocaine ad-
ministration alone.
Within the shell, cocaine increased
transient frequency for 6 min compared
with saline (Fig. 6B). Transient frequency
was significantly greater in the shell com-
pared with the core for the first 3 min after
cocaine administration (Fig. 6B). Raclo-
pride administration in the presence of co-
caine increased transient frequency to the same level as raclopride
administration alone (Fig. 6B). Although cocaine never induced
this magnitude within the NAc core, cocaine-evoked transient
frequency within the shell was not statistically different from the
raclopride condition for 2 min after cocaine administration, a
duration consistent with the time of peak [DA] assessed by mi-
crodialysis using 60 s temporal resolution (Wise et al., 1995).
These data reveal that subregion differences in cocaine-evoked
dopamine transmission (Fig. 5C) are attributable to a greater
number of phasic release events within the NAc shell immediately
after cocaine administration.
Given that the magnitude of raclopride-evoked transients is a
result of increased dopaminergic neuron firing and that this mag-
nitude was achieved in the shell after cocaine, these data suggest
that cocaine may briefly increase the firing of dopaminergic neu-
rons projecting to the shell (Ikemoto, 2007). To test this hypoth-
esis, an additional experiment was conducted (n  5) in which
cocaine administration was preceded by infusion of saline (0.5
l) or a combination of GABA agonists (50 ng of baclofen and 5
ng of muscimol) (McFarland and Kalivas, 2001) directly into the
VTA (Fig. 6C). Intra-VTA infusion saline did not influence do-
pamine transmission (Fig. 6D). However, infusion of GABA ago-
nists eliminated cocaine-evoked increases in transient frequency
within the NAc shell (Fig. 6D) and, as a result, attenuated
cocaine-evoked elevation in [DA] (0.274  0.053 M after intra-
VTA saline; 0.032  0.030 M after intra-VTA GABA agonists;
p  0.01; values obtained from the 90 s sampling window after
cocaine infusion). These data demonstrate that cocaine-evoked
increases in phasic release events within the shell originate from
increased activity of midbrain dopaminergic neurons.
Transient amplitude
Transient amplitude is an index of the concentration of dopa-
mine released (Wightman et al., 1988; Schmitz et al., 2001, 2002).
A representative color plot (Fig. 7A) and concentration trace (Fig.
7B) show that, although the majority of transients are of lower
concentration (30 – 60 nM), higher concentration transients
(100 nM) also occur (Fig. 7A,B). For amplitude quantification,
transient histograms were organized into 10 nM bins (Fig. 7).
Amplitude histograms were compared using a linear mixed
model with rightward shifts in distribution representing in-
creased transient concentration.
Saline infusion did not alter amplitude compared with base-
line sessions (baseline data not shown). After saline administra-
tion in rac/coc subjects, the majority of dopamine transients were
of lower concentration in both subregions (Fig. 7C). Raclopride
increased the concentration of dopamine transients compared
with saline in the core and shell (Fig. 7D), and this is consistent
with studies showing that autoreceptor blockade increases the
concentration of dopamine released (White, 1996; Benoit-
Marand et al., 2001; P. E. Phillips et al., 2002). Raclopride-evoked
increases in transient concentration were significantly greater in
the shell compared with the core (Fig. 7D) and is therefore likely
responsible for subregions differences in [DA] after raclopride
administration (Fig. 4C). In both subregions, cocaine adminis-
tration (in the presence of raclopride) significantly increased
transient amplitude beyond that of raclopride administration
alone (Fig. 7E).
In coc/rac subjects, amplitude distribution after saline admin-
istration showed the same pattern compared with rac/coc sub-
jects (Fig. 7, compare C, F), and transient concentration was









































































Figure 6. Transient frequency. A, Transients per minute after saline (black), raclopride (rac; green), and cocaine administration
in the presence of raclopride (rac-coc; gray). B, Transients per minute after saline (black), cocaine (coc; orange), and raclopride
administration in the presence of cocaine (coc-rac; blue). A, B, Data from the NAc shell are displayed by open circles, and data from
the core are shown as filled circles.  signs indicate statistical significance ( p  0.01) between groups identified by their
appropriate color-coded symbol. Error bars indicate SEM. C, Illustration of the approximate spread of microinfusions (based on dye
infusion) into the VTA and location of carbon-fiber placements within the NAc shell. D, Mean baseline and cocaine-evoked
(obtained from the first 3 min after cocaine infusion) transient frequency after either vehicle infusion (0.5 l of saline) or vehicle
containing the GABA agonists baclofen and muscimol (Bac/Mus) into the VTA. Error bars indicate SEM. *p  0.05.
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Consistent with cocaine-evoked increases in the amount of do-
pamine released (Venton et al., 2006), cocaine significantly in-
creased transient amplitude compared with saline in both subre-
gions (Fig. 7G). Thus, increased transient detection (Robinson
and Wightman, 2004) and the concentration of dopamine exo-
cytosed (Venton et al., 2006) contribute to cocaine-evoked in-
creases in [DA] (Fig. 5C) and transient frequency (Fig. 6B). How-
ever, amplitude histograms after cocaine did not differ between
the core and shell (Fig. 7G). This indicates that enhanced dopa-
mine detection and transient amplitude are not responsible for
subregion differences in dopamine transmission after cocaine
administration (Figs. 5C, 6B). Raclopride administration (in the
presence of cocaine) similarly increased transient amplitude
compared with cocaine administration alone in both subregions
(Fig. 7H).
Transient half-width
Transient half-width measures the duration of a release event, a
process governed by uptake (Wightman et al., 1988; Benoit-
Marand et al., 2000; Cragg and Rice, 2004). Transient duration
was brief after raclopride (Fig. 8A) compared with the very broad
and long-lasting transients evoked by cocaine (Fig. 8B). This is
consistent with uptake being directly influenced by DAT block-
ade (Giros et al., 1996) and indirectly influenced by autoreceptor
blockade (Cass and Gerhardt, 1994; Wu et
al., 2002) [via their interaction with DATs
(Lee et al., 2007)].
Saline infusion did not significantly al-
ter transient half-width compared with
baseline measurements (baseline data not
shown). Raclopride administration signif-
icantly increased transient half-width over
saline levels in both the NAc core (Fig. 8C)
and shell (Fig. 8D). Administration of co-
caine in the presence of raclopride further
increased transient half-width compared
with raclopride treatment alone (Fig.
8C,D). Cocaine administration increased
transient half-width to its maximum mean
value within the NAc core (Fig. 8E) and
shell (Fig. 8F). Administration of raclo-
pride in the presence of cocaine did not
further increase half-width (Fig. 8E,F).
Because transient half-width did not differ
between the core and shell after any drug
treatment, increases in the duration of
phasic dopamine transmission contrib-
utes to drug-evoked increases in [DA] but
not the subregion differences observed.
Discussion
Extracellular [DA] and phasic dopamine
signaling were predictably manipulated by
experimenter delivery of an autoreceptor
blocker (raclopride) as well as cocaine.
Comparison of real-time dopamine trans-
mission after these manipulations allowed
neurochemical characterization of distinct
aspects of dopamine neurotransmission.
Specifically, the occurrence of dopamine
release events was revealed by detection of
dopamine transients. The concentration
of dopamine released and the duration of
release events were examined by analyzing
transient amplitude and half-width, respectively. Analysis of
these specific transmission components provided the first de-
scription of alteration in phasic dopamine signaling after autore-
ceptor blockade and permitted the determination that cocaine
slowed uptake and increased the concentration of ongoing re-
lease events within both the NAc core and shell. However, co-
caine administration caused an additional brief and robust in-
crease in phasic release events only within the NAc shell, and this
effect was eliminated by inactivation of dopaminergic neurons.
Subregion differences in [DA] after cocaine delivery were abol-
ished by raclopride pretreatment, and cocaine administration re-
sulted in a synergistic increase in [DA] in the absence of autoreg-
ulation. Together, these data demonstrate that subregion
differences in [DA] after cocaine administration are attributable
to temporally and regionally specific dopamine release that is
significantly regulated by dopamine autoreceptors.
Autoreceptor regulation of phasic dopamine transmission
This study provides the first assessment of dopamine transients
after autoreceptor blockade. Autoreceptors are located on cell
bodies and terminals of dopaminergic neurons (White, 1996;
Cragg and Greenfield, 1997; Centonze et al., 2002). Blockade of
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Figure 7. Transient amplitude distributions. A, B, A color plot and corresponding [DA] trace from a baseline condition dem-
onstrate the variability of transient amplitudes. Symbols are described in Figure 2. C–H, All dopamine transients within the 15 min
recording sessions were grouped in 10 nM bins beginning with transients between 30 and 39 nM (30) and ending with transients
between 150 and 159 nM (150). C–E, Core–shell comparisons of amplitude histograms for saline (from rac/coc subjects; C),
raclopride (rac; D), and cocaine administration in the presence of raclopride (rac-coc; E). F–H, Core–shell comparisons for saline
(from coc/rac subjects; F), cocaine (coc; G), and raclopride administration in the presence of cocaine (coc-rac; H). C–H, Data from
the NAc core are presented as filled circles, and data from the NAc shell are presented as open circles.  signs indicate statistical
significance ( p  0.01) between groups identified by their appropriate color-coded symbol. Error bars indicate SEM.
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firing (Bunney et al., 1973; Grace and Bun-
ney, 1984a; White, 1996), and the dose of
raclopride used in the present study (1 mg/
kg, i.v.) robustly increases burst firing
(Andersson et al., 1995). Because burst fir-
ing results in phasic dopamine release
(Gonon, 1988), raclopride-evoked tran-
sients reported in the present study likely
originate from burst firing induced by
blockade of somatodendritic autorecep-
tors. Terminal autoreceptors regulate do-
pamine release and synthesis (White,
1996; Benoit-Marand et al., 2001; P. E.
Phillips et al., 2002). Therefore,
raclopride-evoked increases in transient
amplitude are likely mediated by autore-
ceptors located at dopaminergic terminals.
Studies of the time course of electrically
evoked dopamine release show that auto-
receptor blockade slows uptake (Cass and
Gerhardt, 1994; Wu et al., 2002). In the
present study, raclopride administration
caused a gradual rise in [DA] that is attrib-
utable in part to slowed uptake. Further-
more, raclopride administration resulted
in greater transient amplitude within the
shell, and this is therefore likely responsi-
ble for subregion differences in raclopride-
evoked increases in [DA]. This apparent
autoreceptor imbalance between subre-
gions is mostly likely attributable to less
efficient uptake within the shell compared
with the core (Nirenberg et al., 1997). In-
deed, raclopride increased mean transient
half-width over control levels but not if
subjects were pretreated with cocaine,
which confirms that autoreceptors influ-
ence uptake through interaction with
DATs (Lee et al., 2007).
Because autoreceptor regulation of do-
pamine transmission has been extensively
characterized (White, 1996), raclopride-
evoked alterations of transient frequency,
amplitude, and half-width provide reliable
distinctions between phasic release events,
the concentration of dopamine released, and
the duration of increased [DA], respectively.
This novel characterization of pharmacolog-
ically evoked dopamine transmission al-
lowed for unprecedented interpretation of
cocaine-evoked increases in [DA].
Cocaine-evoked dopamine release in the nucleus
accumbens shell
It is known that cocaine-evoked increases in [DA] are action
potential dependent (Nomikos et al., 1990). Within the NAc
core, cocaine induced a gradual increase in [DA] indicative of
slowed uptake of ongoing release events (Venton et al., 2003;
Wightman et al., 2007). Cocaine also increased transient ampli-
tude, which is consistent with increased dopamine exocytosed
per release event (Venton et al., 2006). Thus, enhanced dopamine
detection after DAT blockade (Robinson and Wightman, 2004)
and increased release magnitude (per event) (Venton et al., 2006)
allow a greater number of transients to reach detection limits
(Wightman et al., 2007) and are responsible for increased tran-
sient frequency in the core. However, despite maximum detec-
tion after this high dose of cocaine (3 mg/kg, i.v.), increased
transient frequency within the core did not reach levels produced
by autoreceptor blockade. This suggests that cocaine did not sub-
stantially increase the activity of dopaminergic neurons project-
ing to the core, which is consistent with studies showing that
cocaine does not typically increase firing of dopaminergic neu-
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Figure 8. Transient half-width. A, B, Representative color plot and corresponding [DA] trace after raclopride (A) and cocaine
(B) administration. A, B, Examples are representative of ongoing transients between 5 and 15 min after drug delivery (i.e., after
the initial drug effects described in Figs. 3–5). C–F, Half-width data were taken from all dopamine transients within the 15 min
recording sessions; solid bars represent data from the NAc core, and striped bars represent data from the shell. C, D, Mean transient
half-width after saline (sal; black), raclopride (rac; green), and cocaine administration in the presence of raclopride (rac-coc; gray)
within the core (C) and within the shell (D). E, F, Mean transient half-width after saline (black), cocaine (coc; orange), and
raclopride administration in the presence of cocaine (coc-rac; blue). C–F, Error bars indicate SEM. *p  0.05.
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Consistent with previous studies (Pontieri et al., 1995; Lecca et
al., 2007), cocaine-evoked a substantially greater increase in [DA]
within the NAc shell compared with the core. In addition to the
processes described above, cocaine administration increased the
number of phasic release events within the shell. Cocaine-evoked
transient frequency within this subregion achieved the same
magnitude as that reached after raclopride administration, a ma-
nipulation known to increase dopaminergic neuron firing
(Andersson et al., 1995; White, 1996). This suggests that greater
transient frequency within the shell is attributable to a brief in-
crease in dopaminergic neuron firing.
In support of this, VTA inactivation eliminated the cocaine-
evoked increase in transient frequency within the shell, indicating
that the preferential dopamine transmission within the shell is
attributable to increased activity of dopaminergic neurons. Fur-
thermore, because this manipulation did not completely elimi-
nate baseline transients, the shell-specific increase in transient
frequency would have been detected if this effect were mediated
at the terminal level. Therefore, anatomical differences between
the core and shell (Carboni et al., 2006) and differential afferent
regulation known to influence terminal dopamine transmission
(Howland et al., 2002; A. G. Phillips et al., 2003) do not signifi-
cantly contribute to preferential enhancement of dopamine
transmission with the NAc shell. Although this initially appears
inconsistent with electrophysiology studies showing that cocaine
primarily decreases the firing rate of dopaminergic neurons (Ein-
horn et al., 1988; Shi et al., 2004), these studies primarily targeted
neurons projecting to the NAc core and caudate–putamen but
not the NAc shell (Ikemoto, 2007). Electrophysiological assess-
ment of cocaine administration on shell-projecting neurons
would be valuable, but dopamine release undergoes significant
modulation within terminal fields (Cragg, 2006; Britt and McGe-
hee, 2008). Therefore, real-time electrochemical assessment is
required for unambiguous conformation of terminal dopamine
transmission after cocaine administration.
Real-time measurements allow reliable interpretation of the
origin of increased [DA]. The current study demonstrates that
phasic dopamine release is a consequence of electrical stimula-
tion that mimics bursting (Gonon, 1988) and raclopride treat-
ment known to increase bursting (Andersson et al., 1995). There-
fore, cocaine-evoked increases in phasic release events, beyond
that attributed to enhanced dopamine detection and exocytosis,
may be regarded as originating from increased burst firing. Burst
firing is regulated by glutamate (White, 1996) and cocaine in-
creases glutamate within the VTA, via somatodendritic dopa-
mine release (Bradberry and Roth, 1989) activating D1-type do-
pamine receptors (Kalivas and Duffy, 1995). Therefore, increased
glutamate transmission is likely responsible for direct increases in
phasic release events by cocaine. The VTA contains glutamatergic
neurons (Yamaguchi et al., 2007) and receives glutamatergic af-
ferents from areas ranging from the brainstem to the cortex (Gei-
sler et al., 2007), and it will be important for future studies to
identify the source of cocaine-evoked glutamate release within
the VTA. Additionally, subregion differences in transient fre-
quency were abolished by autoreceptor blockade, suggesting dif-
ferences in somatodendritic autoregulation between core and
shell projection systems (Ikemoto, 2007; Lammel et al., 2008).
Thus, although specific mechanistic details require future inves-
tigation, the current study provides the working hypothesis that
reduced autoregulation (Lammel et al., 2008) of cocaine-evoked
bursting (Shi et al., 2004) among shell-projecting neurons (Ike-
moto, 2007) is responsible for preferentially increased [DA] by
cocaine within the NAc shell.
Conclusion
Dopamine transmission mediates a wide range of adaptive be-
haviors (Becker et al., 2001; Champagne et al., 2004; Roitman et
al., 2004; Aragona et al., 2006; Day et al., 2007), and dopamine
signaling within the NAc shell is critical for potentiated seeking of
natural rewards (Kelley and Berridge, 2002; Everitt and Robbins,
2005). However, intake of artificially purified drugs of abuse
(Nesse and Berridge, 1997; Panksepp et al., 2002) results in a
pathological enhancement of dopamine signaling within the NAc
shell (Di Chiara et al., 2004). Cocaine-evoked dopamine trans-
mission can result in maladaptive increases in incentive motiva-
tion for drug (Robinson and Berridge, 2003) and extremely
strong learned associations to drug-related stimuli (Berke, 2003;
Kelley, 2004). Importantly, drug-related learning is mediated
through activation of low-affinity dopamine receptors within the
shell (Di Chiara and Bassareo, 2007), and high [DA] events are
required to activate these receptors (Richfield et al., 1989; Reyn-
olds et al., 2001; Cheer et al., 2007a). Therefore, the shell-specific
increase in phasic release events described in the present study are
likely essential for primary drug reinforcement (Wise, 2004; Di
Chiara and Bassareo, 2007). Furthermore, the duration of in-
creased phasic release events closely matches the time of peak
subjective pleasure expressed by humans after experimenter-
delivered intravenous cocaine (Volkow et al., 2000), suggesting
the possibility that cocaine-evoked dopamine release may also be
associated with the hedonic impact after cocaine intake (Risinger
et al., 2005; Wheeler et al., 2008). Thus, by resolving distinct
transmission processes that modulate extracellular [DA], the
current study provides insight into a neural consequence of co-
caine intake that may be essential for multiple aspects of drug
reward and abuse.
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